![Rodrigo Ruiz Soto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rodrigo Ruiz Soto
Technik-/Wissenschafts-/F&E-Leiter bei
DECIPHERA PHARMACEUTICALS, INC.
Profil
Rodrigo Ruiz Soto is currently working as the Senior Vice President-Clinical Development at Deciphera Pharmaceuticals, Inc. He previously worked as the Medical Director at Sanofi, Inc. and as the Senior Director-Medical at ImmunoGen, Inc. Dr. Ruiz Soto holds a doctorate degree from Universidad Nacional Autónoma de México.
Aktive Positionen von Rodrigo Ruiz Soto
| Unternehmen | Position | Beginn |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Ehemalige bekannte Positionen von Rodrigo Ruiz Soto
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rodrigo Ruiz Soto
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Universidad Nacional Autónoma de México
 Universidad Nacional Autónoma de México Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
